Crossmark

XLH: CHMP empfiehlt erweiterte Anwendung für Burosumab

Crossref DOI link: https://doi.org/10.1007/s15002-020-2935-2

Published Online: 2020-10-12

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Facharztmagazine, Redaktion
License Information

Text and Data Mining valid from 2020-10-01

Version of Record valid from 2020-10-01
More Information

Article History

First Online: 12 October 2020

Free to read: This content has been made available to all.